Hospital acquired infection controlis the prevention of infections acquired due to viral, bacterial and fungal pathogens from the hospital and its premises which can be harmful for the patient as well as their companions. The Hospital acquired infection control Market was valued at USAD XXX Billion in 2016 and is expected to reach USAD XXX Billion by 2020, at a CAGR of XX% between 2016 and 2020.
These infections are generally caused by pathogens which spread very quickly in the body. Also, due to the patients already effected immune system and vulnerable conditions in a hospital, the infections spread at a greater rate than the normal infections. These infections are treated by prescription of antibiotics, consumption of a proper & healthy diet, and by encouraging natural healing process. The infection can be prevented by keeping the hospital facility premises and surroundings hygienic. The most prevelant type of hospital acquired infections is a urinary tract infection.
Request For Sample@ https://www.kennethresearch.com/sample-request-10064974
Poor infection control methods and lack of proper training among staff have resulted in increased risk of HAIs in hospitals and similar places. This rising prevalence of HAIs which has resulted in increased awareness about HAIs, government programs for awareness about HAIs and promoting policies for increased anti-HAI procedures and technology coupled with increasing number of operations around globe and large-scale use of disinfectors are creating new and greater market opportunities for HAI Control.
However, infrastructural constrains like dearth of supplies, proper buildings, medical and communication equipment along with strict regulatory policies, lack of awareness and untrained and nave staff hamper the growth of global market for HAI Control.
The Hospital acquired infection control market is segmented on the basis of infection prevention, end user,infection testing, and region. The market is further bifurcated into various segments all of which have different contribution in the global market. This is discussed below:
On the basis of Infection Prevention
o Endoscope Reprocessors
Surface Disinfectants/ Disinfectant Robots
> By Formulation
Due to the extensive use of disinfectants across the healthcare industry they account for the largest share in the market among these segments.
On the basis of end user
o Hospitals and Intensive Care Units (ICUs)
o Nursing Homes and Maternity Centres
o Ambulatory Surgical and Diagnostic Centres
Among these Hospitals and ICUs accounted for the largest share owing to the prevalence of a large number of HAIs in these areas.
On the basis of Infection testing
> Drug Resistance Testing
> Disease Testing
> Microbial Testing Instruments
Automated Microbial Identification Systems
Polymerase Chain Reaction (PCR) Instruments
> Reagents and Consumables
> Surveillance Software
> Infection Prevalence
> Hospital Acquired Pneumonia
> Gastrointestinal Infections
> Surgical Site Infections
> Bloodstream Infections
> Urinary Tract Infections (UTI)
> Phenotypic Methods
Nitrate Reductase Assay
> Genotypic Methods
Solid-Phase Hybridization Techniques
Polymerase Chain Reaction Techniques
On the basis of region
o North America
o Asia Pacific
o Rest of the world
Geographically the market is segmented into three different regions:north America, Europe, Asia Pacific and China(APAC) and rest of the world. Among these North America dominates the market in the global world. This is due to the technological advancements in the region coupled with increasing demand for better healthcare facilities and awareness among the masses regarding Hospital Acquired Infections(HAIs). The USA is the largest contributor in the north American region for HAI Control market.
However, Asia Pacific is expected to show the highest growth in the global market in the next five years. This is due to the increasing geriatrics population which in turn results in a higher number of chronic diseases. Also, increasing demand for better healthcare facilities, rising number of medical tourism in developing countries like India and China, rising number of hospitals, greater number of HAIs are also the contributing factors for this future increase in global market share.
The key players who are driving the market of Hospital acquired infection control and determine its future are: Becton, Dickinson and Company (U.S.), Advanced Sterilization Products (U.S., a division of Ethicon US, LLC), Kimberly-Clark Corporation (U.S.), BioMrieux SA (France), Belimed AG (Switzerland), Cantel Medical (U.S.), Sterigenics International LLC. (U.S.), and Synergy Health, plc (U.K.), Getinge Group (Sweden), STERIS Corporation(USA), Sterilization Products Division, 3M company (U.S.)Hoffmann-La Roche Ltd,and Pfizer Inc.
The report contains comprehensive analysis on:
Hospital acquired infection control market segments
Hospital acquired infection control market drivers, restraints and opportunities
Hospital acquired infection control market size and forecast 2016 to 2022
Supply and demand value chain
Hospital acquired infection control market current trends
Competition and major companies
Technology and R&D status
Porters five force analysis
Strategic and critical success factor analysis of key players
The regional analysis of Hospital acquired infection control market includes:
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Rest of Eastern Europe
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
In-depth Market Segmentation
Historical and Projected Market Sizing in terms of volume and value
Recent market trends and Impact Factors
R&D Status and Technology Overview
Extensive Industry Structure Coverage
About Kenneth Research
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Email : Sales@kennethresearch.com
Phone:+1 313 462 0609